Bring Science-Backed Innovation to Your Brand
Enterprise-Scale White Label Programs for the World’s Leading Health and Wellness Companies
Why Partner with Calroy?
Science. Trust. Scale.
Calroy Health Sciences is the developer of clinically backed, doctor-trusted dietary supplements including Arterosil HP®, Vascanox HP®, and Cartigenix HP® —category-leading formulations supported by finished-formula clinical research, patents, and proprietary ingredients.
We make our advanced technologies available to select enterprise-level partners seeking to build premium brands at scale.
What sets us apart:
- Patented & Proprietary Technologies – Access to MonitumRS®, Noxa24®, and RestorCel™ proprietary ingredient systems.
- Clinical Credibility – Cellular studies, human studies, peer-reviewed publications, and physician-led adoption.
- Proven Manufacturing – U.S.-based, GMP-certified production with full traceability and quality control.
- Regulatory Expertise – FDA/FTC-compliant claims support and documentation.
- Scalable Fulfillment – Designed for partners capable of 100K to 10M+ units per year.
Who We Work With
We partner with established and emerging leaders in health and wellness who have the reach and infrastructure to bring best-in-class products to large audiences.
Ideal partners include:
- Consumer wellness and functional health brands
- Medical-grade supplement companies
- DTC / Retail / MLM brands with proven marketing engines
“Our partners value not just our formulas—they value the science & integrity behind them.”
— Ed Hoyt, Co-Founder & CEO, Calroy Health Sciences
What You Can Expect
- Access to our proprietary formulations under your brand/product name
- Collaborative R&D for customized product lines
- Strategic alignment with our science and brand ethos
Let’s Talk
If your organization already has one or more dietary supplement products selling 100,000 to 1,000,000+ units per year, and you’re ready to bring cutting-edge, clinically proven formulations to your customers at scale, we’d love to explore what’s possible.